Clinical differences of influenza subspecies among hospitalized children

Manolya Acar1, Murat Sütçü1, Hacer Aktürk1

  • 1Department of Pediatrics, Pediatric Infectious Diseases and Clinical Immunology Division, İstanbul University İstanbul School of Medicine, İstanbul, Turkey.

Turk Pediatri Arsivi
|April 26, 2017
PubMed

Insights

Influenza A/H1N1 infection in children often presents with more severe clinical disease compared to other influenza subtypes. Understanding these differences is crucial for effective diagnosis and treatment of pediatric influenza cases.

Area of Science:

  • Pediatric Infectious Diseases
  • Virology
  • Clinical Medicine

Background:

  • Influenza subspecies exhibit varying clinical presentations, mortality, and morbidity.
  • Physician awareness of these differences aids in selecting appropriate diagnostic and therapeutic strategies.
  • Early recognition of potential complications is vital for managing pediatric influenza.

Purpose of the Study:

  • To compare the clinical manifestations of different influenza subspecies in hospitalized children.
  • To identify specific risk factors and disease severity associated with each influenza strain.
  • To inform clinical decision-making for pediatric influenza management.

Main Methods:

  • A retrospective study of hospitalized children with confirmed influenza infection via polymerase chain reaction (PCR).
  • Patients were categorized into three groups: Influenza A/H1N1, Influenza A/H3N2, and Influenza B.
  • Data collected included demographics, symptoms, comorbidities, laboratory findings, and clinical outcomes.

Main Results:

  • Influenza A/H1N1 was more prevalent in children with chronic neurologic disorders, while H3N2 was associated with renal failure.
  • Common symptoms included fever, cough, and difficulty breathing; non-respiratory findings involved lymphadenopathy and gastrointestinal issues.
  • Influenza A/H1N1 infection was linked to more severe outcomes, including higher rates of leukopenia, thrombocytopenia, neutropenia, elevated CRP, and antibiotic use, with two deaths reported.

Conclusions:

  • Influenza A/H1N1 infection is associated with more severe clinical disease in hospitalized children.
  • Recognizing subtype-specific differences in pediatric influenza is essential for clinical management.
  • Further research into the distinct pathogenic mechanisms of influenza strains is warranted.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
388
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
446
Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
4.9K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
457
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
340